Radioisotopes/radiation-producing machines (e.g., X-rays, CT scans, fluoroscopy) and associated risks. N/A.
General Checklist

Multi-site Yes/No
• Is this a multi-site study? A multi-site study is generally a study that involves one or more medical or research institutions in which one site takes a lead role.(e.g., multi-site clinical trial) Y
• Is Stanford the coordinating institution or are you the lead investigator for this multi-site study?
• Cancer-Related Studies (studies with cancer endpoints), Cancer Subjects (e.g., clinical trials, behavior/prevention) or Cancer Specimens (e.g., blood, tissue, cells, body fluids with a scientific hypothesis stated in the protocol). • Click "yes" to confirm that you have accessed the website and read the clinicaltrials.gov reporting requirements provided.
• This study will be registered on clinicaltrials.gov?
• Protocol involves studying potentially addicting drugs? N
Tissues and Specimens Yes/No
Protocol # 25734 (New) 
Expedited Form
A protocol must be no more than minimal risk (i.e., "not greater than those ordinarily encountered in daily life") AND must only involve human subjects in one or more of the following paragraphs.
Select one or more of the following paragraphs: 2. Y Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows: a) from healthy, nonpregnant adults who weigh at least 110 pounds. For these subjects, the amounts drawn may not exceed 550 ml in an 8 week period and collection may not occur more frequently than 2 times per week; or b) from other adults and children, considering the age, weight, and health of the subjects, the collection procedure, the amount of blood to be collected, and the frequency with which it will be collected. For these subjects, the amount drawn may not exceed the lesser of 50 ml or 3 ml per kg in an 8 week period and collection may not occur more frequently than 2 times per week.
3. N Prospective collection of biological specimens for research purposes by non invasive means.
N Collection of data through non invasive procedures (not involving general anesthesia or sedation) routinely employed in clinical practice, excluding procedures involving x-rays or microwaves.
Where medical devices are employed, they must be cleared/approved for marketing. (Studies intended to evaluate the safety and effectiveness of the medical device are not generally eligible for expedited review, including studies of cleared medical devices for new indications.) Examples: a) physical sensors that are applied either to the surface of the body or at a distance and do not involve input of significant amounts of energy into the subject or an invasion of the subject's privacy; b) weighing or testing sensory acuity; c) magnetic resonance imaging; d) electrocardiography, electroencephalography, thermography, detection of naturally occurring radioactivity, electroretinography, ultrasound, diagnostic infrared imaging, doppler blood flow, and echocardiography; e) moderate exercise, muscular strength testing, body composition assessment, and flexibility testing where appropriate given the age, weight, and health of the individual. Describe the training you will provide to ensure that all persons assisting with the research are informed about the protocol and their research-related duties and functions. Two sets of teams in the study will each get training:
5.
Nursing team: The lead nurse is a full professor in the School of Medicine, Wang Zhenlin. Dr. Wang and Scott Rozelle will lead training of nursing teams. Dr. Wang will train on administering the hemocue fingerprick blood tests; Scott Rozelle will train team members on how to administer the IRB protocol.
Socioeconomic team: Scott Rozelle will train the socioeconomic survey team. The team will be trained in administering the survey form that will be administered to each caregiver. This form will collect information on age, gender, employment, household characteristics, and nutritional knowledge. The team will also be trained in administering the tests of child development. Scott Rozelle will train team members on how to administer the IRB protocol.
c) Facilities.
Please describe and justify. All testing and surveying will be conducted on-site in respondents' homes, in poor rural villages located in northwest China.
Explain whether you will have sufficient time to conduct and complete the research. Include how much time is required.
Month 1: Preparation
Enumerators (nursing and socioeconomic teams) will be recruited and trained. Materials (including informational materials and surveys) will be completed. Trainers will be recruited and trained.
Month 2: First round of enrollment
The first round of enrollment and baseline testing occurs. All families in the sample villages with babies aged 6-9 months will be enrolled in the study and administered baseline tests.
Month 5: Second round of enrollment
The second round of enrollment and baseline testing occurs. All families in the sample villages with babies aged 6-9 months will be enrolled in the study and administered baseline tests.
Month 6: Interventions begin
Villages will be randomly assigned to one of three intervention groups or a control group: 0.) In the control group, local family planning officials will offer free information on complementary feeding to all families enrolled in the study.
1.) In the social marketing group, local family planning officials will use modern marketing techniques to educate caregivers about the micronutrient supplementation powders and offer the powders for sale for a small fee.
2.) In the free supplementation group, local family planning officials will offer free micronutrient supplementation powders to all families enrolled in the study.
3.) In the conditional cash transfer (CCT) group, local family planning officials will offer free micronutrient supplementation powders to all families enrolled in the study and will pay caregivers if they can show that they have been using the powders.
Month 11: Midline survey
All families participating in the project will be administered a midline survey and blood testing, identical to that performed at the baseline.
Month 23: Endline survey
Month 24-36 Data will be entered and de-identified. Preliminary reports and analyses will be completed. Final reports and Protocol # 25734 (New) PROTOCOL papers will be completed.
e) Access to target population.
Explain and justify whether you will have access to a population that will allow recruitment of the required number of participants.
We will be working with the National Population and Family Planning Center (NPFPC), a ministerial level authoritative body, which will arrange access to the sample villages that will be chosen randomly from a list of all villages in the sample counties.
NPFPC is highly supportive of this project. They want to see improved infant and toddler health, whether achieved by better information, more readily available nutrients, or direct cash transfers.
f) Access to resources if needed as a consequence of the research.
State whether you have medical or psychological resources available that participants might require as a consequence of the research when applicable. Please describe these resources. A team of trained and certified nurses from the School of Medicine, Xian Jiaotong University, under the direction of collaborator, Dr. Zhenlin Wang (Professor) will use hemocue, finger-prick testing cards to test babies' hemoglobin levels. Dr. Wang and her team will be available to address any medical problems that arise during the baseline and follow up blood test portions of the research. Dr. Wang has been involved in many previous studies like this. Most recently, she lead a team of nurses to do health checks for boarding school students for a Ford Foundation supported study led by a team of social scientists from Northwest University, Xian. She has worked for other UN groups.
Note: If in the process of conducting the blood tests our team of nurses find children who appear to have severely low hemoglobin levels (beyond the WHO standards for age and gender for severe iron deficiency), these children will immediately be removed from the study and will be referred for immediate treatment by local doctors. (ii) Email and cell phone (iii) Communication diaries will be kept of all phone communications; email traffic will be stored.
(iv) If any unexpected problem arises, the enumeration and nursing teams will immediately contact Linxiu Zhang.
Purpose a) In layperson's language state the purpose of the study in 3-5 sentences.
The goal of this research is to measure the incidence of baby undernutrition in poor, rural Protocol # 25734 (New) PROTOCOL areas of China, and to evaluate which of three different strategies to improve infant nutrition is most effective relative to a control group.
b) State what the Investigator(s) hope to learn from the study. Include an assessment of the importance of this new knowledge. We propose four specific aims:
(1) To provide new estimates of anemia prevalence among babies in rural China. Very little epidemiological evidence on anemia rates among Chinese babies is available. In our previous work, we have produced preliminary estimates suggesting that prevalence rates among schoolchildren are higher than previous believed, ranging between up to 50% in many rural counties. We suspect that rates are at least as high among the younger children who will participate in this current study.
(2) To compare the behavioral responses of caregivers in rural China when faced with different sets of information and costs for nutritional supplement powders for their children, and to measure the health consequences of each type of response.
(3) To calculate the cost-effectiveness of various approaches for anemia reduction.
A better understanding of these factors is crucial given the significant potential impacts. Iron deficiencies and anemia appear to still stubbornly plague elementary school aged children in China, and we suspect that prevalence rates will be equally high among babies, if not higher. This has never been studied on such a large scale. There has been little systematic evaluative research done to test the effectiveness of different approaches to overcome the nutrition problems.
c) Explain why human subjects must be used for this project. (i.e. purpose of study is to test efficacy of investigational device in individuals with specific condition; purpose of study is to examine specific behavioral traits in humans in classroom or other environment) The purpose of the study is determine the positive impacts on the health and development of very young children in rural China. At the same time, this study intends to uncover the human behavioral responses that enhance or undermine policy implementation to effect positive impacts on health and educational attainment of children in schools.
Study Procedures
a) Describe all the procedures, from screening through closeout, which the human subject must undergo in the research project, including study visits, drug treatments, randomization and the procedures that are part of standard of care. I. Create a baseline of information a.) Establish the nutritional status of babies in China's poor rural areas by conducting Protocol # 25734 (New) PROTOCOL HemoCue 201+ finger prick blood tests of all babies aged 6-9 months in our sample villages.
b.) Administer all babies in the study an age-appropriate test of infant development.
c.) Collect basic household information from caregivers.
II. Implement Interventions a.) In the control group, local family planning officials will offer free information on complementary feeding to all families enrolled in the study.
b.) In the social marketing group, local family planning officials will use modern marketing techniques to educate caregivers about the micronutrient supplementation powders and offer the powders for sale for a small fee. Local family planning officials will also offer the same free information on complementary feeding that is supplied in the control group.
c.) In the free supplementation group, local family planning officials will offer free micronutrient supplementation powders to all families enrolled in the study. Local family planning officials will also offer the same free information on complementary feeding that is supplied in the control group.
d.) In the conditional cash transfer (CCT) group, local family planning officials will offer free micronutrient supplementation powders to all families enrolled in the study and will pay caregivers if they can show that they have been using the powders. Local family planning officials will also offer the same free information on complementary feeding that is supplied in the control group.
Families who receive or purchase the supplementation powders will be told to mix 1 packet into their baby's porridge each day. These supplementation powders have been approved for daily consumption (for anyone over 6 months of age) by China's national Food & Drug Administration. They are available for over the counter purchase in many areas of the country.
III. Midline survey All baseline tests will be repeated.
IV. Endline survey All baseline tests will be repeated.
b) Explain how the above research procedures are the least risky that can be performed consistent with sound research design. 1. The finger prick blood test is the least invasive way to determine low hemoglobin levels. Low hemoglobin levels are indicative of iron deficiency and, if severe, anemia. By using a simple finger prick blood test, we avoid doing any of the more invasive and risky procedures available to determine anemia, which include bone marrow sampling.
2. Results from testing will be recorded by testers in confidence. Later the names will be Protocol # 25734 (New) PROTOCOL removed from the data before the data is released to other researchers. A number will be assigned to each family. The master code with the family names will be stored in a locked filing cabinet in Beijing, in the files of Linxiu Zhang, coPI of the project.
These will not be destroyed because some day we may want to follow up and try to determine the long run impacts of the intervention (hence the need to keep a record of the student participants).
3. We have consulted with nutrition and medical experts to develop the nutrition programs that will be offered to caregivers. The supplementation powders are simple over-thecounter multivitamin supplements that are approved for daily use for babies over 6 months of age. Our nutrition experts have also approved the powders for use in this study. The powders conform almost exactly to the multi-micronutrient "sprinkles" developed by and advocated for by UNICEF.
c) State if deception will be used. If so, provide the rationale and describe debriefing procedures. Since you will not be fully informing the participant in your consent process and form, complete an alteration of consent (in section 13). Submit a debriefing script (in section 16). Deception will not be used in this study. The alternative is the status quo of poor nutrition. The status quo is a continuation of some higher percentage of iron deficiency anemia among babies. f) Will it be possible to continue the more (most) appropriate therapy for the participant(s) after the conclusion of the study? It will be possible for caregivers to continue providing the supplement powders to their children after the conclusion of the study, although it will not be as convenient since we will not continue to bring the supply directly into their villages. Our study does not intend to be a permanent solution to nutrition problems in rural China.
g) Study Endpoint. What are the guidelines or end points by which you can evaluate the different treatments (i.e. study drug, device, procedure) during the study? If one proves to be clearly more effective than another (or others) during the course of a study, will the study be terminated before the projected total participant population has been enrolled? When will the study end if no important differences are detected?
The study endpoint is after the conclusion of the endline survey, in Month 23 of the project.
Background
Protocol # 25734 (New) Severe iron deficiency (anemia) is known to dramatically slow cognitive, behavioral, and physical development and has been identified as one of the most significant health problems internationally. Anemia is a problem that affects children of all ages, especially those in elementary school, and has severe consequences for the educational performance of students in all grades (Nokes, van den Bosch and Bundy 1998). Our own previous studies (2008-2012) have found the rates of iron deficiency anemia among poor elementary students in NW China to be 34% on average. (Luo et al, forthcoming)
Research increasingly indicates the importance of the nutritional programming that occurs in the first 1000 days of life. Nutritional improvements during this brief window have been shown to have large and significant effects on health and development throughout childhood and even into adulthood.
To date, no large-scale study has been conducted to measure the prevalence of undernutrition among babies in rural China. Given our past research of school-aged children in these areas, we suspect that it may be quite high.
We have designed the current study to measure the rates of undernutrition in this important population, and also to identify the most effective way of addressing this undernutrition.
b) Describe any animal experimentation and findings leading to the formulation of the study. N/A.
Radioisotopes or Radiation Machines
a) List all standard of care procedures using ionizing radiation (radiation dose received by a subject that is considered part of their normal medical care). List all research procedures using ionizing radiation (procedures performed due to participation in this study that is not considered part of their normal medical care). List each potential procedure in the sequence that it would normally occur during the entire study. Include the total number of times each procedure may be performed.
Procedures Type b) For radioisotope projects, provide the following radiation-related information:
Identify the radionuclide and chemical form.
For each dosage, provide the number of times the radioisotope will be administered, the route of administration, and the activity that will be administered (mCi).
Provide dosimetry information and reference the source documents (package insert, MIRD calculation, peer reviewed literature). 
Medical Equipment for Human Subjects and Laboratory Animals
If medical equipment used for human patients/participants is also used on animals, describe such equipment and disinfection procedures. N/A
Participant Population
Protocol # 25734 (New) PROTOCOL a) State the following: (i) the number of participants expected to be enrolled at Stanford-affiliated site(s);
(ii)the total number of participants expected to enroll at all sites; (iii) the type of participants (i.e. students, patients with certain cancer, patients with certain cardiac condition) and the reasons for using such participants.
(i) None.
(ii) In total, 1400 babies and their caregivers will be part of this study. Our sample will include 200 villages and we estimate that each village will have 7 babies in our age range (6-9 months).
(iii) Participants will be babies aged 6-9 months at the start of the study and their caregivers. These babies are at an age when nutritional improvements can have the largest impact on future health and development, and also at the age when they can first begin eating complementary foods.
b) State the age range, gender, and ethnic background of the participant population being recruited.
The child participants will be aged 6-9 months at the start of the study. We expect that half will be male and half will be female. All will be ethnic Chinese. We expect that the caregivers will predominantly be women, either in their 20s (mothers) or in middle-age (grandmothers).
c) State the number and rationale for involvement of potentially vulnerable subjects in the study (including children, pregnant women, economically and educationally disadvantaged, decisionally impaired, homeless people, employees and students). Specify the measures being taken to minimize the risks and the chance of harm to the potentially vulnerable subjects and the additional safeguards that have been included in the protocol to protect their rights and welfare.
Approximately 1400 babies will be involved in this study. These babies are at an age when nutritional improvements can have the largest impact on future health and development, and also at the age when they can first begin eating complementary foods.
In order to minimize risks, precautionary measures will include: All families with babies aged 6-9 months at the start of the study will be invited to participate in the study. These families will be identified based on village rosters and also based on the village-level records of our collaborators at the National Population and Family Planning Commission, with whom all families are required by Chinese law to register their births.
h) Inclusion and Exclusion Criteria. Identify inclusion criteria.
All babies aged 6-9 months at the start of the study (and their caregivers) will be included in the study.
Identify exclusion criteria.
We are not including rich, urban areas in the randomized selection. These areas are not known to have large nutrition problems.
Children found in the initial blood test to be severely anemic will be excluded (and sent to a doctor for treatment).
i) Describe your screening procedures, including how qualifying laboratory values will be obtained. If you are collecting personal health information prior to enrollment (e.g., telephone screening), please request a limited waiver of authorization (in section 15). We are not conducting screening. We are randomly selecting villages and automatically enrolling all families with children aged 6-9 months within these villages. We are using no prior information at the individual level.
j) Describe how you will be cognizant of other protocols in which participants might be enrolled. Please explain if participants will be enrolled in more than one study. Participants will not be involved in any other study. k) Payment. Explain the amount and schedule of payment, if any, that will be paid for participation in the study. Substantiate that proposed payments are reasonable and commensurate with the expected contributions of participants and that they do not constitute undue pressure on participants to volunteer for the research study. Include provisions for prorating payment. See payment considerations N/A l) Costs. Please explain any costs that will be charged to the participant. In one of our experimental arms, we will offer the nutritional packets to caregivers at a low cost. This cost will be below market price, and is put into place to test the elasticity of caregivers' demand for the nutritional supplements. The entire study will last 23 months.
(i) No screening.
(ii) Active participation per participant will involve a maximum of 2 hours per survey (baseline, midline, endline), or 6 hours total.
(iii) We estimate that data cleaning and analysis will take 12 months.
Risks
a) For the following categories include a scientific estimate of the frequency, severity, and reversibility of potential risks. Wherever possible, include statistical incidence of complications and the mortality rate of proposed procedures. Where there has been insufficient time to accumulate significant data on risk, a statement to this effect should be included. (In describing these risks in the consent form to the participant it is helpful to use comparisons which are meaningful to persons unfamiliar with medical terminology.) Investigational devices. N/A.
Investigational drugs. Information about risks can often be found in the Investigator's brochure. N/A
Commercially available drugs, reagents or chemicals. Information about risks can often be found in the package insert. Multimicronutrient powders: No risk. This is an over the counter multivitamin supplement powder to be mixed in with the babies' porridge. It has been approved for sale and distribution by the national Chinese government.
Procedures to be performed. Include all investigational, non-investigational and non-invasive procedures (e.g., surgery, blood draws, treadmill tests).
There is only a slight risk of infection with the HemoCue 201+, finger prick blood tests. However, this test is the standard public health methodology and has been shown repeatedly to be safe. The risk is greatly mitigated as we are using trained nurses who clean the finger prior to testing. Each cuvette used is new and sterile. There is some discomfort associated with the test.
Benefits a)
Describe the potential benefit(s) to be gained by the participants or by the acquisition of important knowledge which may benefit future participants, etc. Iron deficiencies and anemia appear to still stubbornly plague elementary school aged children in China. According to the international literature, this can almost certainly account for part of the poor educational performance of China's rural poor. Yet, remarkably, there is little known about the true incidence and seriousness of the micronutrient deficiencies among younger children and their effect on future development. There also has been little systematic evaluative research done to test the effectiveness of different approaches to overcome the nutrition problems.
This study is expected to benefit those children receiving supplements with iron. At the same time, the scientific research results of how iron deficiency levels were reduced and development improved will be best extrapolated to the same age range being tested and we expect will be most relevant to similar at-risk children. Our study's benefits are concentrated among the children participating in our research.
Privacy and Confidentiality
Privacy Protections a) Describe how the conditions under which interactions will occur are adequate to protect the privacy interests of participants (e.g., privacy of physical setting for interviews or data collection, protections for follow-up interactions such as telephone, email and mail communications). Confidentiality Protections: All test results will be recorded in privacy and not shared with others.
All interactions with study participants -except for the group training sessions -will take place in participants' private households, away from strangers and other study participants.
The group training sessions will take place in a small, centrally-located office in the village. All study participants from a single village will attend the training sessions together, as a group.
Confidentiality Protections b) Specify the PHI (protected health information) or other individually identifiable data or specimens you will obtain, use or disclose to others. We will obtain individually identifiable blood test data. However, will not disclose individually identifiable data to other researchers. We will not disclose the real names in any published findings.
All testing data will be entered on a form with the child's name and survey id number. As soon as the data get back to Beijing, a copy will be put into a locked filing cabinet in the Chinese Academy of Sciences (in the office of Linxiu Zhang). The names will then be (i) Trained members of the field survey team will be obtaining consent. All will be trained in the details of the consent process, and will be extremely familiar with the intervention itself.
(ii) Consent will be obtained orally in the caregiver's home before the start of project activities. (iii) Ten minutes will be devoted to consent discussion, including five minutes to describe the study, and five minutes to ask questions. (iv) Yes.
(v) The members of the research team responsible for obtaining consent will be fully trained in the consent process. Caregivers will be notified that participation in the study is voluntary. Consent will be obtained privately. What is the Procedure to assess understanding of the information contained in the consent? How will the information be provided to participants if they do not understand English or if they have a hearing impairment? See /hrpp/Chapter12.html#ch12_2 HRPP Chapter12.2 for guidance. The information will be conveyed to parents orally, according to a predetermined script in Chinese. (The English translation of this script is attached here.) Parents will be asked if they understand what will be required of them.
c)
What steps are you taking to determine that potential participants are competent to participate in the decision-making process? If your study may enroll adults who are unable to consent, describe (i) how you will assess the capacity to consent, (ii) what provisions will be taken if the participant regains the capacity to consent,(iii) who will be used as a legally authorized representative, and (iv) what provisions will be made for the assent of the participant. All caregivers, by the very nature of their role taking care of a young child, can be considered competent to participate in the decision-making process. We will ensure that they are provided with sufficient information to make an informed decision.
Select one of the following regulatory criteria for a waiver of documentation (signature) and provide a protocol-specific justification:
1) 45 CFR 46.117(c)(1). For research that is not subject to FDA regulation, the only record linking the participants and the research would be the consent document,and the principal risk would be potential harm resulting from a breach of confidentiality; each participant will be asked whether he/she wants documentation linking the participant with the research, and the participant's wishes govern.
2)
Y 45 CFR 46.117(c)(2) and 21 CFR 56.109(c)(1). Research (whether it is or is not subject to FDA Protocol # 25734 (New) PROTOCOL
